{
    "title": "Eli Lilly will move forward with all but one trial of its coronavirus antibody treatment after tests in hospitalized patients triggered a 'potential safety concern'",
    "url": "https://www.dailymail.co.uk/health/article-8840155/Eli-Lilly-pause-one-covid-antibody-trials-safety-concern.html",
    "date": "2020-10-14",
    "keywords": [
        "antibody",
        "drug",
        "treatment",
        "coronavirus",
        "president",
        "percent",
        "trial",
        "emergency",
        "safety",
        "side",
        "trump",
        "dexamethasone",
        "covid19",
        "combination",
        "virus",
        "cocktail",
        "approval",
        "therapy",
        "patient",
        "data",
        "regeneron",
        "remdesivir",
        "fda",
        "use",
        "steroid",
        "company",
        "week",
        "infection",
        "time",
        "disease",
        "blood",
        "study",
        "risk",
        "dr",
        "dose",
        "firm",
        "concern",
        "lillys",
        "lycov555",
        "food",
        "administration",
        "amount",
        "nausea",
        "oxygen",
        "abe",
        "authorization",
        "placebo",
        "house",
        "conley",
        "poznansky",
        "mood",
        "tuesday",
        "hold",
        "pause",
        "board",
        "government",
        "warning",
        "johnson",
        "monday",
        "illness",
        "university",
        "headache",
        "immunity",
        "mystery",
        "pathogen",
        "body",
        "dsmb",
        "monotherapy",
        "infusion",
        "pressure",
        "phenomenon",
        "enhancement",
        "friday",
        "system",
        "evidence",
        "share",
        "course",
        "hope",
        "chief",
        "night",
        "specialist",
        "confusion",
        "aggression",
        "load",
        "regncov2",
        "fever",
        "weakness",
        "function",
        "exception",
        "activ3",
        "eli",
        "covid19they",
        "work",
        "bloodstream",
        "development",
        "participant",
        "arm",
        "oxford",
        "astrazenecas",
        "vaccine"
    ],
    "category": [
        "health"
    ]
}